• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

自闭症大鼠丙戊酸模型中环核苷酸系统的改变。

Alterations in the endocannabinoid system in the rat valproic acid model of autism.

机构信息

Physiology, School of Medicine, National University of Ireland Galway, Ireland.

出版信息

Behav Brain Res. 2013 Jul 15;249:124-32. doi: 10.1016/j.bbr.2013.04.043. Epub 2013 May 1.

DOI:10.1016/j.bbr.2013.04.043
PMID:23643692
Abstract

The endocannabinoid system plays a crucial role in regulating emotionality and social behaviour, however it is unknown whether this system plays a role in symptoms associated with autism spectrum disorders. The current study evaluated if alterations in the endocannabinoid system accompany behavioural changes in the valproic acid (VPA) rat model of autism. Adolescent rats prenatally exposed to VPA exhibited impaired social investigatory behaviour, hypoalgesia and reduced lococmotor activity on exposure to a novel aversive arena. Levels of the endocananbinoids, anandamide (AEA) and 2-arachidonylglycerol (2-AG) in the hippocampus, frontal cortex or cerebellum were not altered in VPA- versus saline-exposed animals. However, the expression of mRNA for diacylglycerol lipase α, the enzyme primarily responsible for the synthesis of 2-AG, was reduced in the cerebellum of VPA-exposed rats. Furthermore, while the expression of mRNA for the 2-AG-catabolising enzyme monoacylglycerol lipase was reduced, the activity of this enzyme was increased, in the hippocampus of VPA-exposed animals. CB1 or CB2 receptor expression was not altered in any of the regions examined, however VPA-exposed rats exhibited reduced PPARα and GPR55 expression in the frontal cortex and PPARγ and GPR55 expression in the hippocampus, additional receptor targets of the endocannabinoids. Furthermore, tissue levels of the fatty acid amide hydrolase substrates, AEA, oleoylethanolamide and palmitoylethanolamide, were higher in the hippocampus of VPA-exposed rats immediately following social exposure. These data indicate that prenatal VPA exposure is associated with alterations in the brain's endocannabinoid system and support the hypothesis that endocannabinoid dysfunction may underlie behavioural abnormalities observed in autism spectrum disorders.

摘要

内源性大麻素系统在调节情绪和社交行为方面起着至关重要的作用,但目前尚不清楚该系统是否在与自闭症谱系障碍相关的症状中发挥作用。本研究评估了内源性大麻素系统的改变是否伴随着丙戊酸(VPA)自闭症大鼠模型中的行为变化。产前暴露于 VPA 的青春期大鼠表现出社交探究行为受损、痛觉减退和在暴露于新的厌恶环境时运动活动减少。VPA 暴露动物与生理盐水暴露动物相比,海马体、额叶皮层或小脑内的内源性大麻素,即大麻素(AEA)和 2-花生四烯酰甘油(2-AG)的水平没有改变。然而,VPA 暴露大鼠小脑内二酰基甘油脂肪酶 α(主要负责 2-AG 合成的酶)的 mRNA 表达减少。此外,虽然 2-AG 分解代谢酶单酰基甘油脂肪酶的 mRNA 表达减少,但该酶的活性在 VPA 暴露动物的海马体中增加。在研究的任何区域,CB1 或 CB2 受体表达均未改变,但 VPA 暴露的大鼠在前额叶皮层中表现出 PPARα 和 GPR55 表达减少,在海马体中表现出 PPARγ 和 GPR55 表达减少,这些都是内源性大麻素的额外受体靶标。此外,VPA 暴露大鼠海马体中脂肪酸酰胺水解酶底物 AEA、油酰乙醇酰胺和棕榈酰乙醇酰胺的组织水平在社交暴露后立即升高。这些数据表明,产前 VPA 暴露与大脑内源性大麻素系统的改变有关,并支持内源性大麻素功能障碍可能是自闭症谱系障碍中观察到的行为异常的假说。

相似文献

1
Alterations in the endocannabinoid system in the rat valproic acid model of autism.自闭症大鼠丙戊酸模型中环核苷酸系统的改变。
Behav Brain Res. 2013 Jul 15;249:124-32. doi: 10.1016/j.bbr.2013.04.043. Epub 2013 May 1.
2
Pharmacological inhibition of fatty acid amide hydrolase attenuates social behavioural deficits in male rats prenatally exposed to valproic acid.脂肪酸酰胺水解酶的药理学抑制作用可减轻产前暴露于丙戊酸的雄性大鼠的社会行为缺陷。
Pharmacol Res. 2016 Nov;113(Pt A):228-235. doi: 10.1016/j.phrs.2016.08.033. Epub 2016 Aug 31.
3
Sex-specific autistic endophenotypes induced by prenatal exposure to valproic acid involve anandamide signalling.孕期暴露于丙戊酸引起的性别特异性自闭症内表型与大麻素信号有关。
Br J Pharmacol. 2018 Sep;175(18):3699-3712. doi: 10.1111/bph.14435. Epub 2018 Aug 9.
4
Increasing Endocannabinoid Tone Alters Anxiety-Like and Stress Coping Behaviour in Female Rats Prenatally Exposed to Valproic Acid.产前暴露于丙戊酸会增加内源性大麻素的张力,改变雌性大鼠的焦虑样和应激应对行为。
Molecules. 2021 Jun 18;26(12):3720. doi: 10.3390/molecules26123720.
5
Differential Local Connectivity and Neuroinflammation Profiles in the Medial Prefrontal Cortex and Hippocampus in the Valproic Acid Rat Model of Autism.丙戊酸诱导的自闭症大鼠模型中内侧前额叶皮质和海马的差异局部连接性及神经炎症特征
Dev Neurosci. 2015;37(3):215-31. doi: 10.1159/000375489. Epub 2015 Apr 18.
6
Male-specific alteration in excitatory post-synaptic development and social interaction in pre-natal valproic acid exposure model of autism spectrum disorder.自闭症谱系障碍产前丙戊酸暴露模型中雄性特有的兴奋性突触后发育和社会互动改变。
J Neurochem. 2013 Mar;124(6):832-43. doi: 10.1111/jnc.12147. Epub 2013 Feb 3.
7
Targeting the inhibition of fatty acid amide hydrolase ameliorate the endocannabinoid-mediated synaptic dysfunction in a valproic acid-induced rat model of Autism.靶向抑制脂肪酸酰胺水解酶可改善丙戊酸诱导的自闭症大鼠模型中内源性大麻素介导的突触功能障碍。
Neuropharmacology. 2020 Jan 1;162:107736. doi: 10.1016/j.neuropharm.2019.107736. Epub 2019 Aug 6.
8
Animal model of autism induced by prenatal exposure to valproate: behavioral changes and liver parameters.孕期暴露于丙戊酸致自闭症动物模型:行为改变和肝参数。
Brain Res. 2011 Aug 23;1408:8-16. doi: 10.1016/j.brainres.2011.06.015. Epub 2011 Jun 12.
9
Behavioral alterations in rats prenatally exposed to valproic acid: animal model of autism.产前暴露于丙戊酸的大鼠的行为改变:自闭症动物模型
Neuropsychopharmacology. 2005 Jan;30(1):80-9. doi: 10.1038/sj.npp.1300518.
10
Gender-specific behavioral and immunological alterations in an animal model of autism induced by prenatal exposure to valproic acid.孕期暴露于丙戊酸所致自闭症动物模型中的性别特异性行为和免疫改变
Psychoneuroendocrinology. 2008 Jul;33(6):728-40. doi: 10.1016/j.psyneuen.2008.02.011. Epub 2008 Apr 8.

引用本文的文献

1
Alterations of the endocannabinoid system in autism spectrum disorder: a systematic review and meta-analysis.自闭症谱系障碍中内源性大麻素系统的改变:一项系统综述和荟萃分析。
Eur Arch Psychiatry Clin Neurosci. 2025 Jun 15. doi: 10.1007/s00406-025-02031-x.
2
Sex-Specific Behavioral Features of the Prenatal Valproic Acid Rat Model of Autism Spectrum Disorder.自闭症谱系障碍产前丙戊酸大鼠模型的性别特异性行为特征。
Brain Sci. 2025 Apr 9;15(4):388. doi: 10.3390/brainsci15040388.
3
Increased Serotonin Levels and Unchanged Glutamate and GABA Levels in Thalamic Microdialysates Despite Reduced Cell Numbers in a Valproic Acid-Induced Autism Model.
在丙戊酸诱导的自闭症模型中,尽管丘脑微透析液中的细胞数量减少,但血清素水平升高,谷氨酸和γ-氨基丁酸水平未变。
Neurochem Res. 2024 Dec 5;50(1):45. doi: 10.1007/s11064-024-04299-2.
4
The Endocannabinoid System of the Nervous and Gastrointestinal Systems Changes after a Subnoxious Cisplatin Dose in Male Rats.雄性大鼠接受亚中毒剂量顺铂后神经和胃肠系统的内源性大麻素系统发生变化。
Pharmaceuticals (Basel). 2024 Sep 24;17(10):1256. doi: 10.3390/ph17101256.
5
Efficacy and safety of JNJ-42165279, a fatty acid amide hydrolase inhibitor, in adolescents and adults with autism spectrum disorder: a randomized, phase 2, placebo-controlled study.脂肪酸酰胺水解酶抑制剂JNJ-42165279在青少年和成人自闭症谱系障碍患者中的疗效和安全性:一项随机、2期、安慰剂对照研究。
Neuropsychopharmacology. 2024 Dec;50(2):480-487. doi: 10.1038/s41386-024-02001-2. Epub 2024 Oct 16.
6
Endocannabinoid System Changes throughout Life: Implications and Therapeutic Potential for Autism, ADHD, and Alzheimer's Disease.内源性大麻素系统在生命全程中的变化:对自闭症、注意力缺陷多动障碍和阿尔茨海默病的影响及治疗潜力
Brain Sci. 2024 Jun 10;14(6):592. doi: 10.3390/brainsci14060592.
7
The Use of Compounds Derived from in the Treatment of Epilepsy, Painful Conditions, and Neuropsychiatric and Neurodegenerative Disorders.在癫痫、疼痛病症以及神经精神和神经退行性疾病的治疗中使用来源于 的化合物。
Int J Mol Sci. 2024 May 25;25(11):5749. doi: 10.3390/ijms25115749.
8
Unraveling the Endocannabinoid System: Exploring Its Therapeutic Potential in Autism Spectrum Disorder.解析内源性大麻素系统:探索其在自闭症谱系障碍中的治疗潜力。
Neuromolecular Med. 2024 May 14;26(1):20. doi: 10.1007/s12017-024-08781-6.
9
Region-Specific Brain Volume Changes Emerge in Adolescence in the Valproic Acid Model of Autism and Parallel Human Findings.在丙戊酸自闭症模型中,特定区域的脑容量变化在青少年期出现,与人类研究结果相似。
Dev Neurosci. 2025;47(1):68-80. doi: 10.1159/000538932. Epub 2024 Apr 26.
10
Preclinical Evidence for the Role of the Yin/Yang Angiotensin System Components in Autism Spectrum Disorder: A Therapeutic Target of Astaxanthin.阴阳血管紧张素系统成分在自闭症谱系障碍中的作用的临床前证据:虾青素的治疗靶点
Biomedicines. 2023 Nov 27;11(12):3156. doi: 10.3390/biomedicines11123156.